AGIOS PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Agios Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2012 to Q3 2024.
  • Agios Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $4.06M, a 0.03% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.06M -$1K -0.03% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $4.06M -$1K -0.03% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $4.06M +$100K +2.53% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $4.06M +$101K +2.55% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $4.06M +$154K +3.95% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $4.06M +$102K +2.58% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $3.96M +$1.06M +36.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $3.96M +$1.06M +36.4% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $3.9M +$1M +34.6% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $3.96M +$1.06M +36.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $2.9M Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.9M +$2.9M Dec 31, 2021 10-K 2023-02-23
Q3 2021 $2.9M +$1.55M +115% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $2.9M +$1.33M +84.1% Jun 30, 2021 10-Q 2021-07-29
Q4 2020 $0 $0 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $1.35M +$1.35M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.58M +$1.58M Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $1.8M +$1.74M +2900% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $0 -$238K -100% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $0 -$416K -100% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $0 -$595K -100% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $60K -$1.04M -94.6% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $238K -$653K -73.3% Dec 31, 2018 10-K 2020-02-19
Q3 2018 $416K -$654K -61.1% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $595K -$654K -52.4% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $1.1M -$1.78M -61.8% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $891K -$724K -44.8% Dec 31, 2017 10-K 2019-02-14
Q3 2017 $1.07M -$269K -20.1% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $1.25M -$133K -9.62% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $2.89M +$2.05M +245% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $1.62M +$1M +164% Dec 31, 2016 10-K 2018-02-14
Q3 2016 $1.34M +$661K +97.5% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $1.38M +$722K +109% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $838K +$198K +30.9% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $611K +$21K +3.56% Dec 31, 2015 10-K 2017-02-16
Q3 2015 $678K +$224K +49.3% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $660K +$205K +45.1% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $640K +$173K +37% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $590K +$586K +14650% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $454K +$443K +4027% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $455K -$1.17M -72% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $467K Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $4K -$18K -81.8% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $11K Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $1.62M Jun 30, 2013 10-Q 2013-09-05
Q4 2012 $22K Dec 31, 2012 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.